Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-04 Sale |
2025-03-06 4:24 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
3,548 | $6.29 | $22,317 | 27,414 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 4:17 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
5,914 | $0.63 | $3,726 | 320,714 (Direct) |
View |
| 2024-07-30 Sale |
2024-07-31 4:14 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
2,883 | $1.06 | $3,056 | 326,628 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 7:40 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
22,466 | $1.1782 | $26,470 | 329,511 (Direct) |
View |
| 2024-02-15 Sale |
2024-02-20 4:59 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
5,847 | $1.3312 | $7,783 | 163,772 (Direct) |
View |
| 2023-07-28 Sale |
2023-08-01 5:37 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
2,845 | $1.7 | $4,837 | 156,286 (Direct) |
View |
| 2023-02-15 Sale |
2023-02-17 4:07 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
5,869 | $3.1891 | $18,717 | 64,131 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Option Award |
2025-03-04 4:51 pm |
N/A 2035-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
28,749 | $0 | 50,128 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-29 5:35 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
188,205 | $0 | 351,977 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 7:14 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
13,333 | $0 | 169,619 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 5:38 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
95,000 | $0 | 159,131 (Direct) |
View |
Ownership |
2022-08-19 4:15 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
0 | $0 | 180,000 (Direct) |
View |